Hillel Galitzer's most recent trade in Entera Bio Ltd was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entera Bio Ltd | Hillel Galitzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Hillel Galitzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2025 | 26,316 | 90,573 (0%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Entera Bio Ltd | Hillel Galitzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2024 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Hillel Galitzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2024 | 30,151 | 64,257 (0%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Entera Bio Ltd | Hillel Galitzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 210,000 | 210,000 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Hillel Galitzer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) |